Sun Pharmaceutical Industries Ltd.
Formulation
API
Sun Pharmaceutical Industries Ltd. - Investor
Sun Pharmaceutical Industries Ltd. - Investor
Investor News
INVESTOR
SEARCH
Go
Annual Reports
Home >> Investor >> Annual Reports >> Annual Report 2005-06
Your Directors take pleasure in presenting the Fourteenth Annual Report and Audited Accounts for the year ended 31st March, 2006.
Dividend
Your Directors are pleased to recommend a preference share dividend of 6% p.a. on paid up amount of outstanding preference shares which are still not redeemed, and equity dividend at the rate of 110% (previous year 75%) for the year ended 31 st March, 2006 on the equity share capital.

Voluntary Delisting of your company's equity shares from the Calcutta Stock Exchange
Your Company's shares have been delisted voluntarily from the Calcutta Stock Exchange, Kolkata. Your Company's equity and preference shares continue to remain listed on Bombay Stock Exchange Limited(BSE) and The National Stock Exchange of India Limited (NSE).
Management Discussion and Analysis
The management discussion and analysis of the operations of your company is provided in a separate section on page one, and forms a part of this report.
Demerger of Innovative Research & Development Unit of the company
Your Company has undertaken demerger of its unit of Innovative Research & Development activities and New Drug Delivery systems effective from 1st April,2006, which is presently pending before the Honourable High Court of Gujarat for its approval.
Prev 1 2 3 4 5 Next Top
SITE MAP   DISCLAIMER   PRIVACY POLICY   INTRANET    FIELD FORCE